News

You know you’re in trouble when the pharmacy worker catches your eye and lowers her voice: “You know how much this costs, ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...
The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...
The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...
Obesity doctors break down exactly what this drug will do week-by-week in terms of side effects and weight loss.
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. Buying ...